More cancer drugs on insurance list

More anticancer drugs will be included in medical insurance coverage by the end of September, the National Medical Security Administration said on Saturday.

A new round of negotiations between the administration and pharmaceutical companies to add such drugs to the medical insurance list is scheduled to finish by the end of September, according to the administration.

All the drugs that have been selected as candidates are of high clinical value, and will target different blood cancers or tumors, including colorectal cancer, renal cell carcinoma, lymphoma, and chronic myelogenous leukemia.

The country has exempted anticancer drugs and imported traditional Chinese medicine from import tariffs since May 1.

With the cancelling of tariffs, 12 pharmaceutical companies have recalculated the prices of their products and will submit applications for price adjustments as required by the administration.